➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Mallinckrodt
Johnson and Johnson
McKinsey
Boehringer Ingelheim

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Patent: 7,829,665

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,829,665
Title:Macrocyclic inhibitors of hepatitis C virus replication
Abstract: The embodiments provide compounds of the general Formulae I through general Formula VIII, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
Inventor(s): Blatt; Lawrence M. (Brisbane, CA), Seiwert; Scott D. (Pacifica, CA), Andrews; Steven W. (Longmont, CO), Martin; Pierre (Rheinfelden, CH), Schumacher; Andreas (Efringen-Kirchen, DE), Barnett; Bradley (Northglenn, CO), Eary; C. Todd (Longmont, CO), Kaus; Robert (Longmont, CO), Kercher; Timothy (Boulder, CO), Liu; Weidong (Superior, CO), Lyon; Michael (Superior, CO), Nichols; Paul (Firestone, CO), Wang; Bin (Longmont, CO), Sammakia; Tarek (Boulder, CO), Kennedy; April (Denver, CO), Jiang; Yutong (Longmont, CO)
Assignee: InterMune, Inc. (Brisbane, CA)
Application Number:11/491,126
Patent Claims:see list of patent claims

Details for Patent 7,829,665

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24   Start Trial InterMune, Inc. (Brisbane, CA) 2025-07-25 RX Orphan search
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02   Start Trial InterMune, Inc. (Brisbane, CA) 2025-07-25 RX Orphan search
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02   Start Trial InterMune, Inc. (Brisbane, CA) 2025-07-25 RX Orphan search
Abbvie Inc HUMIRA adalimumab SYRINGE 125057 001 2002-12-31   Start Trial InterMune, Inc. (Brisbane, CA) 2025-07-25 RX search
Abbvie Inc HUMIRA adalimumab VIAL 125057 002 2002-12-31   Start Trial InterMune, Inc. (Brisbane, CA) 2025-07-25 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Dow
Baxter
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.